Followed by the battle of impotency treatments, Pfizer and Hanmi will take a battle over antismoking products
Pfizer Korea and Hanmi Pharmaceutical will take a 4-round battle for their major product.
Hanmi Pharmaceutical, which defeated the original of a impotency drug, ‘Viagra’, with its generic, ‘Palpal’, is now looking forward to see a chance to defeat the top antismoking product with its follow-up p...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
